SARS-CoV-2 infection might be a predictor of mortality in intracerebral hemorrhage

[1]  Aman B Patel,et al.  Characteristics of a COVID-19 Cohort With Large Vessel Occlusion: A Multicenter International Study , 2022, Neurosurgery.

[2]  Lester Y. Leung,et al.  Acute ischaemic stroke associated with SARS-CoV-2 infection in North America , 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  A. Mowla,et al.  Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences , 2021, Neurotoxicity Research.

[4]  A. Babazadeh,et al.  SARS-CoV-2 and Stroke Characteristics , 2021, Stroke.

[5]  M. Azarpazhooh,et al.  SARS-CoV-2 Is a Culprit for Some, but Not All Acute Ischemic Strokes: A Report from the Multinational COVID-19 Stroke Study Group , 2021, Journal of clinical medicine.

[6]  M. Lawton,et al.  Coronavirus disease 2019 (COVID-19) can predispose young to Intracerebral hemorrhage: a retrospective observational study , 2021, BMC Neurology.

[7]  D. Werring,et al.  Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data , 2021, Journal of Neurology.

[8]  A. Hamidianjahromi,et al.  Re: The choice of intravenous thrombolysis for Acute Ischemic Stroke under COVID-19 infection , 2021, Clinical Neurology and Neurosurgery.

[9]  D. Lawrence,et al.  Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients , 2021, Scientific Reports.

[10]  S. Levine,et al.  Intracranial Hemorrhage in COVID-19 Patients , 2021, Journal of Stroke and Cerebrovascular Diseases.

[11]  I. Cheruiyot,et al.  Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients , 2020, Neurological Sciences.

[12]  F. Hassani,et al.  COVID-19 and multiorgan failure: A narrative review on potential mechanisms , 2020, Journal of Molecular Histology.

[13]  W. Mack,et al.  Unusual Pattern of Arterial Macrothrombosis Causing Stroke in a Young Adult Recovered from COVID-19 , 2020, Journal of Stroke and Cerebrovascular Diseases.

[14]  F. Khorvash,et al.  Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series , 2020, Journal of the Neurological Sciences.

[15]  D. Lawrence,et al.  Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients , 2020, medRxiv.

[16]  K. Melmed,et al.  Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System , 2020, Neurocritical Care.

[17]  V. Abedi,et al.  Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study , 2020, EBioMedicine.

[18]  Lester Y. Leung,et al.  Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[19]  J. Antel,et al.  Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic , 2020, Journal of the Neurological Sciences.

[20]  V. Abedi,et al.  SARS-CoV-2 and Stroke Characteristics: A Report from the Multinational COVID-19 Stroke Study Group , 2020, medRxiv.

[21]  A. El Idrissi,et al.  Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients , 2020, Neurological Sciences.

[22]  S. Haseli,et al.  Cerebral venous sinus thrombosis might be under-diagnosed in the COVID-19 era , 2020, eNeurologicalSci.

[23]  L. Sztriha,et al.  Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series , 2020, Brain, Behavior, and Immunity.

[24]  Leora I. Horwitz,et al.  Hemorrhagic stroke and anticoagulation in COVID-19 , 2020, Journal of Stroke and Cerebrovascular Diseases.

[25]  S. Mayer,et al.  Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights , 2020, Journal of Stroke and Cerebrovascular Diseases.

[26]  Mickaël Ohana,et al.  High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study , 2020, Intensive Care Medicine.

[27]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[28]  Arthur S Slutsky,et al.  Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target , 2020, Intensive Care Medicine.

[29]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[30]  F. Rahmani,et al.  Predicting 30-day mortality in patients with primary intracerebral hemorrhage: Evaluation of the value of intracerebral hemorrhage and modified new intracerebral hemorrhage scores , 2018, Iranian journal of neurology.

[31]  B. Yoon,et al.  Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update , 2017, Journal of stroke.

[32]  Douglas G Altman,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. , 2014, International journal of surgery.

[33]  Eric E. Adelman,et al.  Intracerebral hemorrhage mortality is not changing despite declining incidence , 2014, Neurology.

[34]  M. Tripathi,et al.  A prospective study of in-hospital mortality and discharge outcome in spontaneous intracerebral hemorrhage. , 2013, Neurology India.

[35]  P. Mortensen.  EPIDEMIOLOGY , 2012, Schizophrenia Research.

[36]  R. Khalil,et al.  Inflammatory cytokines in vascular dysfunction and vascular disease. , 2009, Biochemical pharmacology.

[37]  Iveta Simera,et al.  The EQUATOR Network: Enhancing the quality and transparency of health research through the use of reporting guidelines , 2008 .

[38]  M. Togha,et al.  Factors associated with in-hospital mortality following intracerebral hemorrhage: a three-year study in Tehran, Iran , 2004, BMC neurology.

[39]  G. Manley,et al.  The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. , 2001, Stroke.